Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Michael E Ohl"'
Autor:
Hiroyuki Suzuki, Alexandre R. Marra, Shinya Hasegawa, Daniel J. Livorsi, Michihiko Goto, Eli N. Perencevich, Michael E. Ohl, Jennifer DeBerg, Marin L. Schweizer
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 1 (2021)
Abstract Objective: To evaluate the frequency of antibiotic prescribing for common infections via telemedicine compared to face-to-face visits. Design: Systematic literature review and meta-analysis. Methods: We searched PubMed, CINAHL, Embase (
Externí odkaz:
https://doaj.org/article/a0a4522143bd4f0295e6aa78d28d71a8
Autor:
Michael E. Ohl, Margaret Carrell, Andrew Thurman, Mark Vander Weg, Teresa Hudson Pharm, Michelle Mengeling, Mary Vaughan-Sarrazin
Publikováno v:
BMC Health Services Research, Vol 18, Iss 1, Pp 1-7 (2018)
Abstract Background Military Veterans in the United States are more likely than the general population to live in rural areas, and often have limited geographic access to Veterans Health Administration (VHA) facilities. In an effort to improve access
Externí odkaz:
https://doaj.org/article/5b3a5826f2bf4435b2361a438a8a5880
Autor:
Michihiko Goto, Jennifer S. McDanel, Makoto M. Jones, Daniel J. Livorsi, Michael E. Ohl, Brice F. Beck, Kelly K. Richardson, Bruce Alexander, Eli N. Perencevich
Publikováno v:
Emerging Infectious Diseases, Vol 23, Iss 11, Pp 1815-1825 (2017)
Bacteremia caused by gram-negative bacteria is associated with serious illness and death, and emergence of antimicrobial drug resistance in these bacteria is a major concern. Using national microbiology and patient data for 2003–2013 from the US Ve
Externí odkaz:
https://doaj.org/article/7824da433f6142b8832e46828435d3f5
Autor:
Michael E. Ohl, Margaret Carrell, Andrew Thurman, Mark Vander Weg, Teresa Hudson, Michelle Mengeling, Mary Vaughan-Sarrazin
Publikováno v:
BMC Health Services Research, Vol 20, Iss 1, Pp 1-1 (2020)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/44ada460f1a446688b7d5a75ca30e8b2
Publikováno v:
American Journal of Preventive Medicine. 61:S108-S117
Introduction Regional partnerships between public health organizations and telehealth programs have the potential to expand access to HIV pre-exposure prophylaxis in rural and small urban areas. However, little is known about the best practices for s
Autor:
Hiroyuki Suzuki, Michihiko Goto, Rajeshwari Nair, Daniel J Livorsi, Poorani Sekar, Michael E Ohl, Daniel J Diekema, Eli N Perencevich, Bruce Alexander, Michael P Jones, Jennifer S McDaniel, Marin L Schweizer
Publikováno v:
Open Forum Infectious Diseases. 9
Background Rifampin is recommended as adjunctive therapy for patients with a Staphylococcus aureus prosthetic joint infection (PJI) managed with debridement, antibiotics, and implant retention (DAIR), with no solid consensus on the optimal duration o
Autor:
Puja Van Epps, Michael E. Ohl, Brice Beck, Takaaki Kobayashi, Lauren A. Beste, Bruce H. Alexander, Marissa M Maier
Publikováno v:
Journal of General Internal Medicine. 37:2482-2488
Healthcare encounters for the diagnosis and treatment of sexually transmitted infections (STIs) are common and represent an opportunity to discuss and initiate HIV pre-exposure prophylaxis (PrEP). Little is known about how frequently PrEP is discusse
Autor:
Hyunkeun Ryan Cho, Michael E. Ohl, Cody Shafer, Angela B. Hoth, Emily E Chasco, Aaron J Siegler
Publikováno v:
AIDS and Behavior
Home specimen self-collection kits with central laboratory testing may improve persistence with PrEP and enhance telehealth programs. We offered Iowa TelePrEP clients the choice of using a home kit or visiting a laboratory site for routine monitoring
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 82:427-430
Cases of HIV, while infrequent, have been reported during tenofovir disoproxil fumarate/emtricitabine use as pre-exposure prophylaxis (PrEP). We describe the incidence of HIV and patterns of PrEP use within the Veterans Health Administration (VHA).We
Autor:
Patrick R. Alba, Kristina Crothers, Rian J. DeFaccio, Matthew Bidwell Goetz, Christopher T Rentsch, Maria C. Rodriguez-Barradas, Michael E. Ohl, Amy C. Justice, Kathleen M. Akgün, Shahida Shahrir, Barbara E. Jones, Joseph T. King, Janet P. Tate, Vincent C. Marconi
Publikováno v:
The European respiratory journal, vol 60, iss 1
BackgroundDexamethasone decreases mortality in coronavirus disease 2019 (COVID-19) patients on intensive respiratory support (IRS) but is of uncertain benefit if less severely ill. We determined whether early (within 48 h) dexamethasone was associate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33f7f1bfe3705122b7e64d8e47f38315
https://researchonline.lshtm.ac.uk/id/eprint/4663940/1/Steroids-COVID-VA-manuscript-28June2021_Submitted.pdf
https://researchonline.lshtm.ac.uk/id/eprint/4663940/1/Steroids-COVID-VA-manuscript-28June2021_Submitted.pdf